Small-cap pharma stock Balaxi Pharmaceuticals has surged over 22% in the last two session, following bulk deal transactions. On March 3, Ebisu Global Opportunities Fund Limited purchased 45.21 lakh shares (8.19%) for ₹53 each. Unico Global Opportunities Fund Limited bought 45.77 lakh shares (8.3%) at the same price of ₹53 per share, as reported by the official data from the exchanges. Conversely, MGC Fund Limited sold 45.21 lakh shares, which also amounts to 8.19%, while Elala India Opportunities Fund offloaded 45.77 lakh shares (8.3%) at ₹53 per share.